164 related articles for article (PubMed ID: 15072224)
1. Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosis.
Hayashi S; Abe K; Matsuoka H; Goya S; Morishita H; Mori M; Arai T; Kida H; Nishino K; Takeda Y; Osaki T; Tachibana I; Kimura K; Yokota S; Inoue Y; Sakatani M
Inflammation; 2004 Feb; 28(1):1-5. PubMed ID: 15072224
[TBL] [Abstract][Full Text] [Related]
2. [Serum-soluble adhesion molecules in patients with idiopathic pulmonary fibrosis and acute respiratory distress syndrome].
Ashitani J; Mukae H; Ihiboshi H; Hiratsuka T; Taniguchi H; Mashimoto H; Matsukura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Sep; 35(9):942-7. PubMed ID: 9396250
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis.
Ihn H; Sato S; Fujimoto M; Takehara K; Tamaki K
Br J Rheumatol; 1998 Nov; 37(11):1188-92. PubMed ID: 9851267
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
[TBL] [Abstract][Full Text] [Related]
5. Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis.
Ateş A; Kinikli G; Turgay M; Duman M
Scand J Immunol; 2004 Mar; 59(3):315-20. PubMed ID: 15030584
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum superoxide dismutase levels correlate with disease severity and neutrophil degranulation in idiopathic pulmonary fibrosis.
Borzì RM; Grigolo B; Meliconi R; Fasano L; Sturani C; Fabbri M; Porstmann T; Facchini A
Clin Sci (Lond); 1993 Sep; 85(3):353-9. PubMed ID: 8403808
[TBL] [Abstract][Full Text] [Related]
7. [Protein C system in patients with idiopathic pulmonary fibrosis--preliminary report].
Kiziewicz A; Zekanowska E; Cieśliński K; Góralczyk K
Pneumonol Alergol Pol; 2008; 76(4):225-8. PubMed ID: 18785126
[TBL] [Abstract][Full Text] [Related]
8. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.
Greene KE; King TE; Kuroki Y; Bucher-Bartelson B; Hunninghake GW; Newman LS; Nagae H; Mason RJ
Eur Respir J; 2002 Mar; 19(3):439-46. PubMed ID: 11936520
[TBL] [Abstract][Full Text] [Related]
9. Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance.
Honda Y; Kuroki Y; Shijubo N; Fujishima T; Takahashi H; Hosoda K; Akino T; Abe S
Respiration; 1995; 62(2):64-9. PubMed ID: 7784711
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome?
Meliconi R; Lalli E; Borzì RM; Sturani C; Galavotti V; Gunella G; Miniero R; Facchini A; Gasbarrini G
Thorax; 1990 Jul; 45(7):536-40. PubMed ID: 2118691
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis.
Yanaba K; Takehara K; Sato S
Ann Rheum Dis; 2004 May; 63(5):583-7. PubMed ID: 15082492
[TBL] [Abstract][Full Text] [Related]
12. Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Cervello M; Virruso L; Lipani G; Giannitrapani L; Soresi M; Carroccio A; Gambino R; Sanfililippo R; Marasà L; Montalto G
J Cancer Res Clin Oncol; 2000 Jun; 126(6):345-51. PubMed ID: 10870645
[TBL] [Abstract][Full Text] [Related]
13. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of soluble adhesion molecules in sera and BAL fluid of individuals infected with human T-cell lymphotropic virus type 1.
Seki M; Higashiyama Y; Kadota J; Mukae H; Yanagihara K; Tomono K; Kohno S
Chest; 2000 Dec; 118(6):1754-61. PubMed ID: 11115469
[TBL] [Abstract][Full Text] [Related]
15. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.
Günther A; Schmidt R; Nix F; Yabut-Perez M; Guth C; Rosseau S; Siebert C; Grimminger F; Morr H; Velcovsky HG; Seeger W
Eur Respir J; 1999 Sep; 14(3):565-73. PubMed ID: 10543276
[TBL] [Abstract][Full Text] [Related]
16. Elevation of serum soluble E-selectin and VCAM-1 in severe asthma.
Hamzaoui A; Ammar J; El Mekki F; Borgi O; Ghrairi H; Ben Brahim M; Hamzaoui K
Mediators Inflamm; 2001 Dec; 10(6):339-42. PubMed ID: 11817675
[TBL] [Abstract][Full Text] [Related]
17. Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositis.
Kubo M; Ihn H; Yamane K; Yazawa N; Kikuchi K; Soma Y; Tamaki K
Br J Dermatol; 2000 Aug; 143(2):392-8. PubMed ID: 10951151
[TBL] [Abstract][Full Text] [Related]
18. Surfactant protein-A in lung lavage fluid obtained from patients with idiopathic pulmonary fibrosis.
Behera D; Kaur S; Sathyanarayana G; Majumdar S
J Assoc Physicians India; 2002 Nov; 50():1409-12. PubMed ID: 12583473
[TBL] [Abstract][Full Text] [Related]
19. Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis--correlation with disease activity.
Czech W; Schöpf E; Kapp A
Br J Dermatol; 1996 Jan; 134(1):17-21. PubMed ID: 8745880
[TBL] [Abstract][Full Text] [Related]
20. Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trail.
Wamil BD; Thurman GB; Sundell HW; DeVore RF; Wakefield G; Johnson DH; Wang YF; Hellerqvist CG
J Cancer Res Clin Oncol; 1997; 123(3):173-9. PubMed ID: 9119883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]